NF-1819
NF-1819 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. NF-1819 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. NF-1819 displays high membrane permeability and brain penetrant.
Product Specifications
CAS Number
1881244-28-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
463.46
Molecular Formula
C24H22FN5O4
Notes
Research use only, not for human use.
Receptor
Lipase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6336587-01 0.2 mL
PPP1R3G, CT (PPP1R3G, Putative protein phosphatase 1 regulatory inhibitor subunit 3G) (PE)
Ask
View Details 
MBS6336587-02 5x 0.2 mL
PPP1R3G, CT (PPP1R3G, Putative protein phosphatase 1 regulatory inhibitor subunit 3G) (PE)
Ask
View Details GTR15135857 1 Vial
Lentiviral human GALNS shRNA (UAS) - Lentiviral human GALNS shRNA (UAS) (25)
Ask
View Details 
1320000-35-70-21.500MG 500 mg
Ɑ-Butyric Acid NHS Ester-ω-Pentynoic (2-Boc-Amino) PEG
Ask
View Details